Literature DB >> 1561334

Chiari I malformations: clinical and radiologic reappraisal.

A D Elster1, M Y Chen.   

Abstract

Clinical findings and magnetic resonance (MR) images in 68 patients with Chiari I malformations were retrospectively analyzed to identify those radiologic features that correlated best with clinical symptoms. A statistically significant (P = .03) female predominance of the malformation was observed, with a female: male ratio of approximately 3:2. Associated skeletal anomalies were seen in 24% of patients. Syringomyelia was detected in 40% of patients, most commonly between the C-4 and C-6 levels. Of the 25 patients who presented with spinal symptoms, 23 (92%) proved to have a syrinx at MR imaging. When the syrinx extended into the medulla (n = 3), however, brain stem symptoms predominated. Patients with objective brain stem or cerebellar signs had the largest mean tonsillar herniations. Patients with tonsillar herniations greater than 12 mm were invariably symptomatic, but approximately 30% of patients with tonsils herniating 5-10 mm below the foramen magnum were asymptomatic at MR imaging. "Incidental" Chiari I malformations are thus much more common than previously recognized, and careful clinical assessment remains the cornerstone for proper diagnosis and management.

Entities:  

Mesh:

Year:  1992        PMID: 1561334     DOI: 10.1148/radiology.183.2.1561334

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  95 in total

1.  Phase-contrast MR imaging of the cervical CSF and spinal cord: volumetric motion analysis in patients with Chiari I malformation.

Authors:  E Hofmann; M Warmuth-Metz; M Bendszus; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 2.  History, anatomic forms, and pathogenesis of Chiari I malformations.

Authors:  Edgardo Schijman
Journal:  Childs Nerv Syst       Date:  2004-02-05       Impact factor: 1.475

3.  The Chiari malformations.

Authors:  Donald M Hadley
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 4.  Diagnosis of Chiari I malformation and related syringomyelia: radiological and neurophysiological studies.

Authors:  Massimo Caldarelli; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2004-03-18       Impact factor: 1.475

Review 5.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

6.  Cardiac-Related Spinal Cord Tissue Motion at the Foramen Magnum is Increased in Patients with Type I Chiari Malformation and Decreases Postdecompression Surgery.

Authors:  Braden J Lawrence; Mark Luciano; John Tew; Richard G Ellenbogen; John N Oshinski; Francis Loth; Amanda P Culley; Bryn A Martin
Journal:  World Neurosurg       Date:  2018-05-04       Impact factor: 2.104

7.  Bilateral perysilvian polymicrogyria in Chiari I malformation.

Authors:  Alberto Spalice; Pasquale Parisi; Mario Mastrangelo; Francesca De Luca; Alberto Verrotti; Paola Iannetti
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

8.  The post-syrinx syndrome: stable central myelopathy and collapsed or absent syrinx.

Authors:  E I Bogdanov; John D Heiss; E G Mendelevich
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

9.  Dissociated sensory loss and muscle wasting in a young male with headaches: syringomyelia with type 1 Arnold-Chiari malformation.

Authors:  Mueez Waqar; Anjum Habib Vohra
Journal:  BMJ Case Rep       Date:  2013-10-29

10.  Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia.

Authors:  Dan S Heffez; Ruth E Ross; Yvonne Shade-Zeldow; Konstantinos Kostas; Sagar Shah; Robert Gottschalk; Dean A Elias; Alan Shepard; Sue E Leurgans; Charity G Moore
Journal:  Eur Spine J       Date:  2004-04-09       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.